CIK 0000948320
- Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760238453
- Phone
- +1 866-351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 13,900 shares at $0.15 ($2,016)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 75,000 shares at an average $0.17 ($12,494)
- 4 Open-market buy Director bought 200,000 shares at an average $0.18 ($36,180)
- 4 Open-market buy Chief Executive Officer bought 49,487 shares at $0.17 ($8,561)
- 4 Open-market buy Chief Executive Officer bought 74,128 shares at an average $0.16 ($11,826)
- 4 Gift Chief Executive Officer gave 100,000 shares (gift)
- 4 Open-market buy Director bought 25,000 shares at an average $0.12 ($3,119)
- 4 Open-market buy Director bought 69,000 shares at an average $0.13 ($8,957)
- 4 Open-market buy Director bought 25,000 shares at $0.12 ($3,000)
- 4 Open-market buy Director bought 54,965 shares at an average $0.13 ($7,177)
- 4 Open-market buy Chief Executive Officer bought 50,000 shares at $0.13 ($6,500)
- 4 Open-market buy Director bought 51,035 shares at an average $0.14 ($7,029)
- 4 Open-market buy Chief Operating Officer bought 4,687 shares at $0.16 ($750)
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at an average $0.10 ($2,489)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 10 of 12 · 230 filings